Identification of Antisense RNA NRAS-AS and Its Preliminary Exploration of the Anticancer Regulatory Mechanism
Reduced NRAS-AS expression is frequently observed in HCC and is inversely related to NRAS gene expression, suggesting a role in HCC pathogenesis through NRAS regulation. Targeting antisense RNA NRAS-AS could hold promise as a therapeutic target and diagnostic biomarker for HCC.
Authors
- Jinhua Xiang (ORCID: https://orcid.org/0000-0002-7052-4972)
- Xuming Hu (ORCID: https://orcid.org/0000-0002-6973-8252)
- Hengmi Cui (ORCID: https://orcid.org/0000-0001-5139-5370)
- Liping Wang (ORCID: https://orcid.org/0000-0001-9095-8682)
- Chenyue Tao
Institutions
- Foothills Medical Centre (CA)
- Northern Jiangsu People's Hospital (CN)
- Yangzhou University (CN)
Publication Details
- Journal
- Genes
- Published
- 2024-11-27
- DOI
- https://doi.org/10.3390/genes15121524
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00